4.6 Review

Pneumonia and Streptococcus pneumoniae vaccine

Journal

ARCHIVES OF PHARMACAL RESEARCH
Volume 40, Issue 8, Pages 885-893

Publisher

PHARMACEUTICAL SOC KOREA
DOI: 10.1007/s12272-017-0933-y

Keywords

Pneumonia; Streptococcus pneumoniae; Pneumococcal vaccine

Funding

  1. National Research Foundation [NRF-2015R1 A2 A1 A10052511]

Ask authors/readers for more resources

Pneumonia is an inflammatory disease of the lung, responsible for high morbidity and mortality worldwide. It is caused by bacteria, viruses, fungi, or other microorganisms. Streptococcus pneumoniae, a gram-positive bacterium with over 90 serotypes, is the most common causative agent. Moreover, comorbid factors including heart failure, renal disease, and pulmonary disease could increase the risk of pneumococcal pneumonia. Since the advent of the pneumococcal vaccine in the 1980s, the incidence of pneumonia has decreased significantly. However, current vaccines confer only limited protection against serotypes included in the vaccine. Thus, to overcome this limitation, new types of pneumococcal vaccines have been sought and under clinical trials. In this review, we discuss pneumonia and summarize the various types of pneumococcal vaccines in progress.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available